Zenas Biopharma (usa), Llc

This study tests an experimental drug called obexelimab to see if it can prevent flare-ups in people with IgG4-related disease, a rare condition that causes swelling and damage in organs. About 194 adults with active disease will receive either the drug or a placebo. The main goa…

This study tests an experimental drug called obexelimab in 93 people with relapsing multiple sclerosis (MS). The goal is to see if it can reduce new brain lesions and relapses better than a placebo. Participants receive either the drug or a placebo, and their brain scans and symp…